Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
NIH‑funded Vibrant Moms project outlines plan to reduce preeclampsia in the Texas Panhandle
Summary
Researchers from Texas Tech described a multi‑county Vibrant Moms project funded by the NIH that found a 6.6% preeclampsia rate locally and proposed phase‑2 implementation trials to screen and offer low‑dose aspirin interventions through community partners.
Researchers and community partners updated the Amarillo City Council on Vibrant Moms, an NIH‑funded maternal‑health initiative focused on preventing preeclampsia across six Texas Panhandle counties.
Dr. Christine Garner and Dr. Julie St. John said the project’s community needs assessment — which included focus groups, key informant interviews, photovoice and a survey with more than 3,500 respondents — found a local preeclampsia rate of about 6.6%, higher than national averages. The team identified barriers such as delayed prenatal care, lack of insurance, distance to services and low awareness of preeclampsia risk factors.
Phase 2, a proposed five‑year implementation trial under NIH review, would test community‑based strategies including screening for risk factors, using community health workers for outreach and, when clinically appropriate, physician‑recommended low‑dose aspirin to prevent preeclampsia. The project partners include more than 30 community organizations and plans to train lay health workers and create warm handoffs into clinical care and insurance enrollment assistance.
Council thanked the team and noted overlap with planned city women’s clinic services; no council action was required other than acceptance of the update.
What’s next: The team expects NIH review of a phase‑2 proposal; staff and partners will continue community engagement and coordination with city health resources.
